A retrospective chart review to investigate clinical remission in patients with severe asthma treated with biologics in the United Kingdom National Health Service - REMISSION UK

Study identifier:D2287R00189

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

A retrospective chart review to investigate clinical remission in patients with severe asthma treated with biologics in the United Kingdom National Health Service

Medical condition

asthma

Phase

Phase 4

Healthy volunteers

No

Study drug

Biologic treatment

Sex

All

Estimated Enrollment

425

Study type

Observational

Age

18 Years - 130 Years

Date

Study Start Date: 22 Feb 2024
Estimated Primary Completion Date: 27 Sept 2024
Estimated Study Completion Date: 27 Sept 2024

Study design

Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria